Over the past 12 months, 2 insiders at Parabilis Medicines, Inc. filed 9 open-market SEC Form 4 transactions on PBLS: 9 purchases worth $7.4M and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Jul 22, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 22, 26 | Ra Capital Management, L.p.Director, 10% Owner | BUY | 47.3K | $29.77 | $1.4M |
| Jul 21, 26 | Ra Capital Management, L.p.Director, 10% Owner | BUY | 37.7K | $30.00 | $1.1M |
| Jul 20, 26 | Ra Capital Management, L.p.Director, 10% Owner | BUY | 98.4K | $27.72 | $2.7M |
| Jun 15, 26 | Alan Sebulsky | BUY | 5.0K | $27.10 | $130K |
| Jun 12, 26 | Alan Sebulsky | BUY | 8.4K | $27.67 | $233K |
Over the past 12 months, insiders at Parabilis Medicines, Inc. filed 9 open-market purchases worth $7.4M and 0 sales worth $0 on PBLS, which makes them net buyers over the period. The most recent Form 4 was filed on Jul 22, 26.
The largest recent open-market PBLS insider purchase in our data was $2.7M by Ra Capital Management, L.p., Director, 10% Owner, filed on Jul 20, 26.
2 different insiders at Parabilis Medicines, Inc. filed open-market SEC Form 4 transactions on PBLS over the last 12 months.
InsiderTape plots every PBLS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Parabilis Medicines, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →